General information about company |
|||
|---|---|---|---|
| Scrip Code | 500596 | ||
| NSE Symbol | HINDUNILVR | ||
| MSEI Symbol | NOTLISTED | ||
| ISIN | INE030A01027 | ||
| Name of company | Hindustan Unilever Limited | ||
| Type of company | Main Board | ||
| Class of security | Equity | ||
| Date of start of financial year | 01-Apr-2024 | ||
| Date of end of financial year | 31-Mar-2025 | ||
| Date of board meeting when results were approved | 24-Apr-2025 | ||
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 24-Mar-2025 | ||
| Description of presentation currency | INR (in Actuals) | ||
| Reporting Type | Quarterly | ||
| Reporting Quarter | Fourth quarter | ||
| Nature of report standalone or consolidated | Consolidated | ||
| Whether results are audited or unaudited for the quarter ended | Audited | ||
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Audited | ||
| Segment Reporting | Multi segment | ||
| Description of single segment | |||
| Start date and time of board meeting | 24-Apr-2025 08:45:00 | ||
| End date and time of board meeting | 24-Apr-2025 10:15:00 | ||
| Whether cash flow statement is applicable on company | Yes | ||
| Type of cash flow statement | Cash Flow Indirect | ||
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion | ||
Financial Results Ind-AS |
|||
|---|---|---|---|
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-Jan-2025 | 01-Apr-2024 |
| B | Date of end of reporting period | 31-Mar-2025 | 31-Mar-2025 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Part I | Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column. | ||
| 1 | Income | ||
| Revenue from operations | 156700000000 | 631210000000 | |
| Other income | 3090000000 | 10170000000 | |
| Total income | 159790000000 | 641380000000 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 48300000000 | 194580000000 |
| (b) | Purchases of stock-in-trade | 28020000000 | 112730000000 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | -90000000 | -1530000000 |
| (d) | Employee benefit expense | 8560000000 | 30770000000 |
| (e) | Finance costs | 800000000 | 3950000000 |
| (f) | Depreciation, depletion and amortisation expense | 3470000000 | 13550000000 |
| (f) | Other Expenses | ||
| 1 | Advertising and promotion | 15100000000 | 61990000000 |
| 2 | Others | 20620000000 | 84160000000 |
| Total other expenses | 35720000000 | 146150000000 | |
| Total expenses | 124780000000 | 500200000000 | |
| 3 | Total profit before exceptional items and tax | 35010000000 | 141180000000 |
| 4 | Exceptional items | -1380000000 | 3050000000 |
| 5 | Total profit before tax | 33630000000 | 144230000000 |
| 6 | Tax expense | ||
| 7 | Current tax | 8490000000 | 36200000000 |
| 8 | Deferred tax | 380000000 | 1240000000 |
| 9 | Total tax expenses | 8870000000 | 37440000000 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0 | 0 |
| 11 | Net Profit Loss for the period from continuing operations | 24760000000 | 106790000000 |
| 12 | Profit (loss) from discontinued operations before tax | 0 | 0 |
| 13 | Tax expense of discontinued operations | 0 | 0 |
| 14 | Net profit (loss) from discontinued operation after tax | 0 | 0 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | -10000000 | -80000000 |
| 16 | Total profit (loss) for period | 24750000000 | 106710000000 |
| 17 | Other comprehensive income net of taxes | -220000000 | -190000000 |
| 18 | Total Comprehensive Income for the period | 24530000000 | 106520000000 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | 24640000000 | 106490000000 | |
| Total profit or loss, attributable to non-controlling interests | 110000000 | 110000000 | |
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | 24420000000 | 106300000000 | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | 110000000 | 220000000 | |
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 2350000000 | 2350000000 | |
| Face value of equity share capital | 1 | 1 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | 491670000000 | |
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 10.48 | 45.32 | |
| Diluted earnings (loss) per share from continuing operations | 10.48 | 45.32 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 10.48 | 45.32 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 10.48 | 45.32 | |
| 24 | Debt equity ratio | ||
| 25 | Debt service coverage ratio | ||
| 26 | Interest service coverage ratio | ||
| 27 | Disclosure of notes on financial results | ||
Remarks |
|
|---|---|
| Debt equity ratio | |
| Debt service coverage ratio | |
| Interest service coverage ratio | |
Statement of Asset and Liabilities |
|||
|---|---|---|---|
| Particulars | Year ended (dd-mm-yyyy) | ||
| Date of start of reporting period | 01-Apr-2024 | ||
| Date of end of reporting period | 31-Mar-2025 | ||
| Whether results are audited or unaudited | Audited | ||
| Nature of report standalone or consolidated | Consolidated | ||
| Assets | |||
| 1 | Non-current assets | ||
| Property, plant and equipment | 86250000000 | ||
| Capital work-in-progress | 10090000000 | ||
| Investment property | 0 | ||
| Goodwill | 174660000000 | ||
| Other intangible assets | 282440000000 | ||
| Intangible assets under development | 0 | ||
| Biological assets other than bearer plants | 0 | ||
| Investments accounted for using equity method | 570000000 | ||
| Non-current financial assets | |||
| Non-current investments | 20000000 | ||
| Trade receivables, non-current | 0 | ||
| Loans, non-current | 870000000 | ||
| Other non-current financial assets | 7630000000 | ||
| Total non-current financial assets | 8520000000 | ||
| Deferred tax assets (net) | 170000000 | ||
| Other non-current assets | 15590000000 | ||
| Total non-current assets | 578290000000 | ||
| 2 | Current assets | ||
| Inventories | 44150000000 | ||
| Current financial asset | |||
| Current investments | 37510000000 | ||
| Trade receivables, current | 38190000000 | ||
| Cash and cash equivalents | 60710000000 | ||
| Bank balance other than cash and cash equivalents | 14830000000 | ||
| Loans, current | 460000000 | ||
| Other current financial assets | 14880000000 | ||
| Total current financial assets | 166580000000 | ||
| Current tax assets (net) | 0 | ||
| Other current assets | 9550000000 | ||
| Total current assets | 220280000000 | ||
| 3 | Non-current assets classified as held for sale | 230000000 | |
| 4 | Regulatory deferral account debit balances and related deferred tax Assets | 0 | |
| Total assets | 798800000000 | ||
| Equity and liabilities | |||
| 1 | Equity | ||
| Equity attributable to owners of parent | |||
| Equity share capital | 2350000000 | ||
| Other equity | 491670000000 | ||
| Total equity attributable to owners of parent | 494020000000 | ||
| Non controlling interest | 2070000000 | ||
| Total equity | 496090000000 | ||
| 2 | Liabilities | ||
| Non-current liabilities | |||
| Non-current financial liabilities | |||
| Borrowings, non-current | 0 | ||
| Trade payables, non-current | |||
| (A) Total outstanding dues of micro enterprises and small enterprises | 0 | ||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 0 | ||
| Total Trade payable | 0 | ||
| Other non-current financial liabilities | 19230000000 | ||
| Total non-current financial liabilities | 19230000000 | ||
| Provisions, non-current | 15280000000 | ||
| Deferred tax liabilities (net) | 66850000000 | ||
| Deferred government grants, Non-current | 0 | ||
| Other non-current liabilities | 35980000000 | ||
| Total non-current liabilities | 137340000000 | ||
| Current liabilities | |||
| Current financial liabilities | |||
| Borrowings, current | 10000000 | ||
| Trade payables, current | |||
| (A) Total outstanding dues of micro enterprises and small enterprises | 2630000000 | ||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 110520000000 | ||
| Total Trade payable | 113150000000 | ||
| Other current financial liabilities | 16840000000 | ||
| Total current financial liabilities | 130000000000 | ||
| Other current liabilities | 9590000000 | ||
| Provisions, current | 6750000000 | ||
| Current tax liabilities (Net) | 19030000000 | ||
| Deferred government grants, Current | 0 | ||
| Total current liabilities | 165370000000 | ||
| 3 | Liabilities directly associated with assets in disposal group classified as held for sale | 0 | |
| 4 | Regulatory deferral account credit balances and related deferred tax liability | 0 | |
| Total liabilities | 302710000000 | ||
| Total equity and liabilites | 798800000000 | ||
| Disclosure of notes on assets and liabilities | |||
Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results |
|||||||
|---|---|---|---|---|---|---|---|
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
| Date of start of reporting period | 01-Jan-2025 | 01-Apr-2024 | |||||
| Date of end of reporting period | 31-Mar-2025 | 31-Mar-2025 | |||||
| Whether accounts are audited or unaudited | Audited | Audited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| 1 | Home Care | 58150000000 | 229580000000 | ||||
| 2 | Beauty & Wellbeing | 32650000000 | 135230000000 | ||||
| 3 | Personal Care | 21260000000 | 91660000000 | ||||
| 4 | Foods | 38960000000 | 152940000000 | ||||
| 5 | Others (includes Exports, Consignment, etc.) | 5680000000 | 21800000000 | ||||
| Total Segment Revenue | 156700000000 | 631210000000 | |||||
| Less: Inter segment revenue | |||||||
| Revenue from operations | 156700000000 | 631210000000 | |||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| 1 | Home Care | 10930000000 | 44290000000 | ||||
| 2 | Beauty & Wellbeing | 10460000000 | 41880000000 | ||||
| 3 | Personal Care | 3980000000 | 16310000000 | ||||
| 4 | Foods | 6270000000 | 28080000000 | ||||
| 5 | Others (includes Exports, Consignment, etc.) | 1080000000 | 4400000000 | ||||
| Total Profit before tax | 32720000000 | 134960000000 | |||||
| i. Finance cost | 800000000 | 800000000 | |||||
| ii. Other Unallocable Expenditure net off Unallocable income | -1700000000 | -1700000000 | |||||
| Profit before tax | 33620000000 | 144150000000 | |||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| 1 | Home Care | 55730000000 | 55730000000 | ||||
| 2 | Beauty & Wellbeing | 43910000000 | 43910000000 | ||||
| 3 | Personal Care | 36920000000 | 36920000000 | ||||
| 4 | Foods | 515710000000 | 515710000000 | ||||
| 5 | Others (includes Exports, Consignment, etc.) | 11220000000 | 11220000000 | ||||
| Total Segment Asset | 663490000000 | 663490000000 | |||||
| Un-allocable Assets | 135310000000 | 135310000000 | |||||
| Net Segment Asset | 798800000000 | 798800000000 | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| 1 | Home Care | 52570000000 | 52570000000 | ||||
| 2 | Beauty & Wellbeing | 42520000000 | 42520000000 | ||||
| 3 | Personal Care | 26910000000 | 26910000000 | ||||
| 4 | Foods | 37300000000 | 37300000000 | ||||
| 5 | Others (includes Exports, Consignment, etc.) | 4730000000 | 4730000000 | ||||
| Total Segment Liabilities | 164030000000 | 164030000000 | |||||
| Un-allocable Liabilities | 138680000000 | 138680000000 | |||||
| Net Segment Liabilities | 302710000000 | 302710000000 | |||||
| Disclosure of notes on segments | |||||||
Other Comprehensive Income |
|||
|---|---|---|---|
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-Jan-2025 | 01-Apr-2024 |
| B | Date of end of reporting period | 31-Mar-2025 | 31-Mar-2025 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Remeasurements of the net defined benefit plans | -220000000 | -220000000 |
| Total Amount of items that will not be reclassified to profit and loss | -220000000 | -220000000 | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | -50000000 | -50000000 |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| 1 | Fair value of debt instruments through other comprehensive income | 0 | 0 |
| 2 | Fair value of cash flow hedges through other comprehensive income | -50000000 | -20000000 |
| Total Amount of items that will be reclassified to profit and loss | -50000000 | -20000000 | |
| 4 | Income tax relating to items that will be reclassified to profit or loss | 0 | 0 |
| 5 | Total Other comprehensive income | -220000000 | -190000000 |
Cash flow statement, indirect |
||||||
|---|---|---|---|---|---|---|
| Particulars | Year ended (dd-mm-yyyy) | |||||
| A | Date of start of reporting period | 2024-04-01 | ||||
| B | Date of end of reporting period | 2025-03-31 | ||||
| C | Whether results are audited or unaudited | Audited | ||||
| D | Nature of report standalone or consolidated | Consolidated | ||||
| Part I | Blue color marked fields are non-mandatory. | |||||
| Statement of cash flows | ||||||
| Cash flows from used in operating activities | ||||||
| Profit before tax | 144230000000 | |||||
| Adjustments for reconcile profit (loss) | ||||||
| Adjustments for finance costs | 3720000000 | |||||
| Adjustments for decrease (increase) in inventories | -5840000000 | |||||
| Adjustments for decrease (increase) in trade receivables, current | -8460000000 | |||||
| Adjustments for decrease (increase) in trade receivables, non-current | 0 | |||||
| Adjustments for decrease (increase) in other current assets | -2420000000 | |||||
| Adjustments for decrease (increase) in other non-current assets | -870000000 | |||||
| Adjustments for other financial assets, non-current | -30000000 | |||||
| Adjustments for other financial assets, current | -1870000000 | |||||
| Adjustments for other bank balances | 0 | |||||
| Adjustments for increase (decrease) in trade payables, current | 8330000000 | |||||
| Adjustments for increase (decrease) in trade payables, non-current | 0 | |||||
| Adjustments for increase (decrease) in other current liabilities | 1520000000 | |||||
| Adjustments for increase (decrease) in other non-current liabilities | 0 | |||||
| Adjustments for depreciation and amortisation expense | 13630000000 | |||||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0 | |||||
| Adjustments for provisions, current | 2450000000 | |||||
| Adjustments for provisions, non-current | -1730000000 | |||||
| Adjustments for other financial liabilities, current | 2120000000 | |||||
| Adjustments for other financial liabilities, non-current | -1110000000 | |||||
| Adjustments for unrealised foreign exchange losses gains | 40000000 | |||||
| Adjustments for dividend income | 0 | |||||
| Adjustments for interest income | 7550000000 | |||||
| Adjustments for share-based payments | 110000000 | |||||
| Adjustments for fair value losses (gains) | -2560000000 | |||||
| Adjustments for undistributed profits of associates | 0 | |||||
| Other adjustments for which cash effects are investing or financing cash flow | -5950000000 | |||||
| Other adjustments to reconcile profit (loss) | 0 | |||||
| Other adjustments for non-cash items | 3780000000 | |||||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0 | |||||
| Total adjustments for reconcile profit (loss) | -2690000000 | |||||
| Net cash flows from (used in) operations | 141540000000 | |||||
| Dividends received | 0 | |||||
| Interest paid | 0 | |||||
| Interest received | 0 | |||||
| Income taxes paid (refund) | 22680000000 | |||||
| Other inflows (outflows) of cash | 0 | |||||
| Net cash flows from (used in) operating activities | 118860000000 | |||||
| Cash flows from used in investing activities | ||||||
| Cash flows from losing control of subsidiaries or other businesses | 0 | |||||
| Cash flows used in obtaining control of subsidiaries or other businesses | 0 | |||||
| Other cash receipts from sales of equity or debt instruments of other entities | 0 | |||||
| Other cash payments to acquire equity or debt instruments of other entities | 0 | |||||
| Other cash receipts from sales of interests in joint ventures | 0 | |||||
| Other cash payments to acquire interests in joint ventures | 0 | |||||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0 | |||||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0 | |||||
| Proceeds from sales of property, plant and equipment | 130000000 | |||||
| Purchase of property, plant and equipment | 12540000000 | |||||
| Proceeds from sales of investment property | 0 | |||||
| Purchase of investment property | 0 | |||||
| Proceeds from sales of intangible assets | -210000000 | |||||
| Purchase of intangible assets | 0 | |||||
| Proceeds from sales of intangible assets under development | 0 | |||||
| Purchase of intangible assets under development | 0 | |||||
| Proceeds from sales of goodwill | 0 | |||||
| Purchase of goodwill | 0 | |||||
| Proceeds from biological assets other than bearer plants | 0 | |||||
| Purchase of biological assets other than bearer plants | 0 | |||||
| Proceeds from government grants | 0 | |||||
| Proceeds from sales of other long-term assets | 0 | |||||
| Purchase of other long-term assets | 0 | |||||
| Cash advances and loans made to other parties | 0 | |||||
| Cash receipts from repayment of advances and loans made to other parties | 0 | |||||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0 | |||||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0 | |||||
| Dividends received | 0 | |||||
| Interest received | 8350000000 | |||||
| Income taxes paid (refund) | 0 | |||||
| Other inflows (outflows) of cash | 69000000000 | |||||
| Net cash flows from (used in) investing activities | 64730000000 | |||||
| Cash flows from used in financing activities | ||||||
| Proceeds from changes in ownership interests in subsidiaries | 0 | |||||
| Payments from changes in ownership interests in subsidiaries | 0 | |||||
| Proceeds from issuing shares | 0 | |||||
| Proceeds from issuing other equity instruments | 0 | |||||
| Payments to acquire or redeem entity's shares | 0 | |||||
| Payments of other equity instruments | 0 | |||||
| Proceeds from exercise of stock options | 0 | |||||
| Proceeds from issuing debentures notes bonds etc | 0 | |||||
| Proceeds from borrowings | 0 | |||||
| Repayments of borrowings | 0 | |||||
| Payments of lease liabilities | 4980000000 | |||||
| Dividends paid | 124730000000 | |||||
| Interest paid | 1300000000 | |||||
| Income taxes paid (refund) | 0 | |||||
| Other inflows (outflows) of cash | 0 | |||||
| Net cash flows from (used in) financing activities | -131010000000 | |||||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 52580000000 | |||||
| Effect of exchange rate changes on cash and cash equivalents | ||||||
| Effect of exchange rate changes on cash and cash equivalents | 0 | |||||
| Net increase (decrease) in cash and cash equivalents | 52580000000 | |||||
| Cash and cash equivalents cash flow statement at beginning of period | 8120000000 | |||||
| Cash and cash equivalents cash flow statement at end of period | 60700000000 | |||||
Details of Impact of Audit Qualification |
|
|---|---|
| Whether results are audited or unaudited | Audited |
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Auditor's opinion | |
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results | Yes |
| Sr No. | Audit firm's name | Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI | Certificate valid upto | ||
| 1 | M/s. Walker Chandiok & Co. LLP | Yes | 31-May-2025 | ||
|---|---|---|---|---|---|
Financial details |
|||
| Sr. | Particulars | Audited Figures (as reported before adjusting for qualifications) | Adjusted Figures (audited figures after adjusting for qualifications) |
| 1 | Turnover / Total income | ||
| 2 | Total Expenditure | ||
| 3 | Net Profit/(Loss) | ||
| 4 | Earnings Per Share | ||
| 5 | Total Assets | ||
| 6 | Total Liabilities | ||
| 7 | Net Worth | ||
Signatories detail |
|
|---|---|
| Name of CEO / Managing director | |
| Name of CFO | |
| Name of audit committee chairman | |
| Name of statutory auditor | |
| Name of other signatory, if any, with designation | |
| Place | |
| Date | |